GSDMB and neoplasm: Next, to validate if the combination of lapatinib and CQ on HER2/GSDMB positive tumors would be an effective therapeutic approach, we assayed its functional effect on tumor growth in vivo using two different preclinical models, zebrafish, and mice (Fig. 4).